Certified by Founder Lodge
Xontogeny
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Xontogeny (zon-TOJ-uh-nee) is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients
| Company | Date | Round | Raised |
|---|---|---|---|
CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
CARGO Therapeutics
Avalyn Pharma Inc.
CereVasc
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)